Briacell Therapeutics Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Briacell Therapeutics Corp
TickerBCTXL
CIK #0001610820
CUSIP107930125
SectorLife Sciences - Pharmaceutical Preparations
Address3Rd Floor, Bellevue Centre, 235-15Th Str, West Vancouver, BC V7T 2X1
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Briacell Therapeutics Corp 2021-06-15 27.2 M Exemption: 506(b) · Duration: One year or less · Commission: $2,175,680 · Revenue: Decline to Disclose
Ansell Capital Corp 2014-06-20 0.3 M Exemption: 506(b) · Remaining: $581,973 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001610820] 10-K
[0001610820] 10-Q
[0001610820] 3
[0001610820] 4
[0001610820] 6-K
[0001610820] 8-K
[0001610820] D
[0001610820] SC 13D
[0001610820] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Citadel Advisors LLC Briacell Therapeutics Corp [2026-01-23] 0.0
Plambeck Jeremy Myung JAE Briacell Therapeutics Corp [2025-10-10] 0.0
Iroquois Capital Management LLC Briacell Therapeutics Corp [2025-07-28] 0.0
CVI Investments Inc Briacell Therapeutics Corp [2025-07-22] 0.0
CVI Investments Inc Briacell Therapeutics Corp [2025-05-01] 0.0
3I LP Briacell Therapeutics Corp [2025-02-10] 0.0
CVI Investments Inc Briacell Therapeutics Corp [2024-09-16] 8239.0
Copia Fund Cayman LP Briacell Therapeutics Corp [2024-01-08] 0.0
Lynwood Capital Management Inc Briacell Therapeutics Corp [2022-08-01] 5.6
Southwest Private Capital Inc Briacell Therapeutics Corp [2022-04-25] 5.1
KJ Harrison & Partners Inc Briacell Therapeutics Corp [2021-09-13] 6.23
L5 Capital Inc Briacell Therapeutics Corp [2021-09-07] 10.0
Lynwood Capital Management Inc Briacell Therapeutics Corp [2021-08-17] 5.8
AULT Global Holdings Inc Briacell Therapeutics Corp [2021-08-09] 6.15
L5 Capital Inc Briacell Therapeutics Corp [2021-06-28] 5.01
CVI Investments Inc Briacell Therapeutics Corp [2021-06-14] 5.0
Altium Capital Management LP Briacell Therapeutics Corp [2021-03-08] 8.9
L1 Capital Global Opportunities Master Fund Ltd Briacell Therapeutics Corp [2021-03-05] 16.3
Sabby Management LLC Briacell Therapeutics Corp [2021-03-03] 0.87
Empery Asset Management LP Briacell Therapeutics Corp [2021-03-02] 8.89
Lind Global Macro Fund LP Briacell Therapeutics Corp [2021-02-26] 9.9
Bigger Capital Fund L P Briacell Therapeutics Corp [2021-02-26] 4.9
Form 3/4/5 Filer 2011 - 2026
BriaCell Therapeutics Corp
Lustig Marc
Williams William V
Bondarenko Jamieson
Lopez-Lago Miguel A
Embro-Pantalony Vaughn C
Taub Rebecca
Levin GADI
Gross Jane A
del Priore Giuseppe
Schmieg Martin E
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lustig Marc
Common Shares
2024-05-14 Buy 902,935 $2.22 2,004,516
Lustig Marc
Common Stock Warrants · derivative
2024-05-14 Buy 902,935
Bondarenko Jamieson
Common Shares
2022-12-28 Buy 28,000 $4.58 128,240
Williams William V
Warrant · derivative
2022-12-23 Buy 2,530 $1.94 4,908
Bondarenko Jamieson
Common Shares
2022-12-20 Buy 22,000 $5.35 117,700
13F Ownership Over TimeHoldersShares Held
2026-03-31 15 3,573,930
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com